Search Result |
Top |
| Entry | Name | Name(TN) | Disease |
|---|---|---|---|
| D00254 | Carmustine (JAN/USP/INN) |
Bicnu (TN) Gliadel (TN) |
Glioma [DS:H00042] Glioblastoma [DS:H00042] Medulloblastoma [DS:H01667] Astrocytoma [DS:H00042] Ependymoma [DS:H00042] Multiple myeloma [DS:H00010] Hodgkin's lymphoma [DS:H00007] Non-Hodgkin's lymphomas [DS:H02418] |
| D00266 | Chlorambucil (JAN/USP/INN) | Leukeran (TN) |
Chronic lymphatic (lymphocytic) leukemia [DS:H00005] Giant follicular lymphoma [DS:H01613] Hodgkin's disease [DS:H00007] |
| D00287 |
Cyclophosphamide (USP) Cyclophosphamide hydrate (JP18) |
Cytoxan (TN) Neosar (TN) |
Hodgkin's disease [DS:H00007] Burkitt lymphoma [DS:H00008] Multiple myeloma [DS:H00010] Chronic lymphocytic leukemia [DS:H00005] Acute myelogenous leukemia [DS:H00003] Acute lymphoblastic (stem-cell) leukemia [DS:H00001 H00002] Mycosis fungoides [DS:H01463] Neuroblastoma [DS:H00043] Adenocarcinoma of the ovary [DS:H00027] Retinoblastoma [DS:H01513] Carcinoma of the breast [DS:H00031] Nephrotic syndrome [DS:H01657] |
| D00288 | Dacarbazine (JAN/USP/INN) | DTIC-Dome (TN) |
Malignant melanoma [DS:H00038] Hodgkin's disease [DS:H00007] |
| D00363 | Lomustine (USP/INN) | Gleostine (TN) | Hodgkin's lymphoma [DS:H00007] |
| D00478 | Procarbazine hydrochloride (JP18/USP) | Matulane (TN) | Hodgkin's disease [DS:H00007] |
| D01068 | Vinblastine sulfate (JP18/USP) |
Exal (TN) Velban (TN) |
Hodgkin's disease [DS:H00007] Mycosis fungoides [DS:H01463] Carcinoma of the testis [DS:H00023] Kaposi's sarcoma [DS:H00041] Letterer-Siwe disease [DS:H01512] Choriocarcinoma [DS:H00028] Carcinoma of the breast [DS:H00031] |
| D01275 | Doxorubicin hydrochloride (JP18/USP) |
Adriacin (TN) Adriamycin (TN) Doxil (TN) Rubex (TN) |
Ovarian cancer [DS:H00027] AIDS-related Kaposi's sarcoma [DS:H00041] Multiple myeloma [DS:H00010] Acute lymphoblastic leukemia [DS:H00001 H00002] Acute myeloblastic leukemia [DS:H00003] Hodgkin lymphoma [DS:H00007] Non-Hodgkin lymphoma [DS:H02418] Breast cancer [DS:H00031] Wilms' tumor [DS:H02301] Neuroblastoma [DS:H00043] Soft tissue sarcoma [DS:H02427] Ovarian carcinoma [DS:H00027] Transitional cell bladder carcinoma [DS:H00022] Thyroid carcinoma [DS:H00032] Gastric carcinoma [DS:H00018] |
| D02115 | Methotrexate sodium |
Trexall (TN) Rasuvo (TN) |
Choriocarcinoma [DS:H00028] Breast cancer [DS:H00031] Epidermoid cancers of the head and neck [DS:H02420] Mycosis fungoides [DS:H01463] Lung cancer [DS:H00013 H00014] Non-Hodgkin's lymphomas [DS:H02418] Psoriasis [DS:H01656] Rheumatoid arthritis [DS:H00630] Juvenile rheumatoid arthritis [DS:H01672] |
| D02177 | Bleomycin sulfate (JP18/USP) | Blenoxane (TN) |
Squamous cell carcinoma [DS:H00040] Hodgkin's disease [DS:H00007] Non-Hodgkin's lymphoma [DS:H02418] Testicular carcinoma [DS:H00023] Choriocarcinoma [DS:H00028] |
| D02197 |
Vincristine sulfate (JP18/USP) VCR |
Marqibo (TN) Oncovin (TN) Vincasar (TN) Vincrex (TN) |
Acute lymphoblastic leukemia (Philadelphia chromosome-negative) [DS:H00001 H00002] Hodgkin's disease [DS:H00007] Non–Hodgkin's malignant lymphomas [DS:H02418] Rhabdomyosarcoma [DS:H00037] Neuroblastoma [DS:H00043] Wilms' tumor [DS:H02301] |
| D02994 |
Rituximab (USAN/INN) Rituximab (genetical recombination) (JAN) Rituximab (genetical recombination) [Rituximab biosimilar 1] (JAN) Rituximab (genetical recombination) [Rituximab biosimilar 2] (JAN) Rituximab-abbs Rituximab-pvvr Rituximab-arrx |
Rituxan (TN) Riabni (TN) Truximab (TN) |
Non-Hodgkin's lymphoma (CD20-positive) [DS:H02418] Chronic lymphocytic leukemia (CD20-positive) [DS:H00005] Rheumatoid arthritis [DS:H00630] Granulomatosis with polyangiitis; Wegener's granulomatosis [DS:H01655] Microscopic polyangiitis [DS:H01658] Pemphigus vulgaris [DS:H01648] |
| D04489 |
Ibritumomab tiuxetan (USAN/INN) Ibritumomab tiuxetan (genetical recombination) (JAN) |
Zevalin (TN) | Low-grade or follicular non-Hodgkin's lymphoma (CD20-directed) [DS:H00005 H00011 H01613] |
| D05324 | Adsorbed hepatitis B vaccine (huGK-14 cell origin) (JAN) | ||
| D07085 | Bendamustine hydrochloride (JAN/USAN) |
Treanda (TN) Ribomustin (TN) |
Chronic lymphocytic leukemia [DS:H00005] Non-Hodgkin lymphoma [DS:H02418] |
| D08971 | Plerixafor (JAN/USAN/INN) | Mozobil (TN) |
Non-Hodgkin's lymphoma [DS:H02418] Multiple myeloma [DS:H00010] |
| D09587 |
Brentuximab vedotin (USAN/INN) Brentuximab vedotin (genetical recombination) (JAN) |
Adcetris (TN) |
Hodgkin lymphoma [DS:H00007] Anaplastic large cell lymphoma [DS:H01601] Peripheral T-cell lymphoma (CD30 expressing) [DS:H01892] Mycosis fungoides (CD30 expressing) [DS:H01463] |
| D10316 |
Nivolumab (USAN/INN) Nivolumab (genetical recombination) (JAN) |
Opdivo (TN) |
Melanoma [DS:H00038] Non-small cell lung cancer [DS:H00014] Small cell lung cancer [DS:H00013] Malignant pleural mesothelioma [DS:H00015] Renal cell carcinoma [DS:H00021] Hodgkin lymphoma [DS:H00007] Squamous cell carcinoma of the head and neck [DS:H02420] Urothelial carcinoma [DS:H00022] Colorectal cancer (MSI-H or dMMR) [DS:H00020] Hepatocellular carcinoma [DS:H00048] Esophageal squamous cell carcinoma [DS:H00017] Gastric cancer [DS:H00018] Esophageal adenocarcinoma [DS:H00017] |
| D10574 |
Pembrolizumab (USAN) Pembrolizumab (genetical recombination) (JAN) |
Keytruda (TN) |
Melanoma [DS:H00038] Non-small cell lung cancer (PD-L1 expressed) [DS:H00014] Head and neck squamous cell carcinoma (PD-L1 expressed) [DS:H02420] Head and neck squamous cell carcinoma [DS:H02420] Hodgkin lymphoma [DS:H00007] Mediastinal large B-cell lymphoma [DS:H02434] Urothelial carcinoma [DS:H00022] Solid tumor (MSI-H or dMMR) [DS:H02421] Colorectal cancer (MSI-H) [DS:H00020] Gastric cancer (HER2 positive) [DS:H00018] Esophageal cancer (PD-L1 expressed) [DS:H00017] Cervical cancer (PD-L1 expressed) [DS:H00030] Hepatocellular carcinoma [DS:H00048] Merkel cell carcinoma [DS:H01555] Renal cell carcinoma [DS:H00021] Endometrial carcinoma (MSI-H or dMMR) [DS:H00026] Solid tumor (TMB-H) [DS:H02421] Cutaneous squamous cell carcinoma [DS:H00040] Breast cancer (triple-negative, PD-L1 expressed) [DS:H00031] |
| D11416 |
Naxitamab (USAN) Naxitamab-gqgk |
Danyelza (TN) | Neuroblastoma [DS:H00043] |
| D12241 | Regdanvimab (INN) | Regkirona (TN) |
| [ KEGG | DISEASE | DRUG | MEDICUS ] |